Showing results (41-50 of 1,865) with videos related to
Sort By:
Pageof 187
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1987
Frequency analysis of class I MHC-reactive Lyt-2+ and class II MHC-reactive L3T4+ IL 2-secreting T lymphocytesK Heeg, C Steeg, J Schmitt, et al.Journal of Immunological Methods|April 25, 1997
A rapid method for semiquantitative analysis of the human V beta-repertoire using TaqManR PCRR Lang, K Pfeffer, H Wagner, et al.European Journal of Immunology|July 1, 1991
Dissection of signals controlling T cell function and activation: H7, an inhibitor of protein kinase C, blocks induction of primary T cell proliferation by suppressing interleukin (IL)2 receptor expression without affecting IL2 productionH Hengel, B Allig, H Wagner, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1987
Frequency of herpes simplex virus-specific murine cytotoxic T lymphocyte precursors in mitogen- and antigen-driven primary in vitro T cell responsesH Hengel, M Lindner, H Wagner, et al.The Journal of Experimental Medicine|August 1, 1985
Allorestricted cytotoxic T cells. Large numbers of allo-H-2Kb-restricted antihapten and antiviral cytotoxic T cell populations clonally develop in vitro from murine splenic precursor T cellsJ Reimann, D Kabelitz, K Heeg, et al.Scandinavian Journal of Immunology|September 1, 1995
Identification of H-2Kb binding and immunogenic peptides from human papilloma virus tumour antigens E6 and E7S Bauer, K Heeg, H Wagner, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1993
Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motifG B Lipford, M Hoffman, H Wagner, et al.Immunology|August 24, 1999
DNA activates human immune cells through a CpG sequence-dependent mannerM Bauer, K Heeg, H Wagner, et al.Immunology|September 30, 2000
Poly-guanosine motifs costimulate antigen-reactive CD8 T cells while bacterial CpG-DNA affect T-cell activation via antigen-presenting cell-derived cytokinesG B Lipford, S Bendigs, K Heeg, et al.Immunology|February 1, 1995
Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6G B Lipford, S Bauer, H Wagner, et al.Pageof 187